{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:22:10Z","timestamp":1789024930311,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","thebonejournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.bone.2016.06.017","type":"journal-article","created":{"date-parts":[[2016,7,2]],"date-time":"2016-07-02T20:19:30Z","timestamp":1467490770000},"page":"152-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"special_numbering":"C","title":["Teriparatide in patients with osteoporosis and type 2 diabetes"],"prefix":"10.1016","volume":"91","author":[{"given":"Ann V.","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imre","family":"Pavo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahangir","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damon P.","family":"Disch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dara","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Krege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2016.06.017_bb0005","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","article-title":"Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporos. Int."},{"issue":"5","key":"10.1016\/j.bone.2016.06.017_bb0010","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/aje\/kwm106","article-title":"Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture","volume":"166","author":"Janghorbani","year":"2007","journal-title":"Am. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.bone.2016.06.017_bb0015","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1210\/jc.2012-1896","article-title":"Risk factors for subtrochanteric and diaphyseal fractures: The study of osteoporotic fractures","volume":"98","author":"Napoli","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2016.06.017_bb0020","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10654-012-9674-x","article-title":"Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies","volume":"7","author":"Ma","year":"2012","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.bone.2016.06.017_bb0025","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1001\/jama.2011.715","volume":"305","author":"Schwartz","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2016.06.017_bb0030","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1007\/s00198-011-1713-z","article-title":"Interpretation and use of FRAX in clinical practice","volume":"22","author":"Kanis","year":"2011","journal-title":"Osteoporos. Int."},{"issue":"2","key":"10.1016\/j.bone.2016.06.017_bb0035","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/jbmr.556","article-title":"FRAX underestimates fracture risk in patients with diabetes","volume":"27","author":"Giangregorio","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2016.06.017_bb0040","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1007\/s00198-014-2822-2","article-title":"Does diabetes modify the effect of FRAX risk factors for predicting major osteoporotic and hip fracture?","volume":"25","author":"Leslie","year":"2014","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2016.06.017_bb0045","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2014.06.013","article-title":"Bone damage in type 2 diabetes mellitus","author":"Carnevale","year":"2014","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.bone.2016.06.017_bb0050","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/820615","article-title":"Osteoporosis, fractures, and diabetes","author":"Jackuliak","year":"2014","journal-title":"Int. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.bone.2016.06.017_bb0055","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.maturitas.2014.08.003","article-title":"Increased fracture risk in patients with type 2 diabetes mellitus: an overview of the underlying mechanisms and the usefulness of imaging modalities and fracture risk assessment tools","volume":"79","author":"de Waard","year":"2014","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.bone.2016.06.017_bb0060","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11684-013-0243-9","article-title":"Impact of diabetes and its treatments on skeletal diseases","volume":"7","author":"Yan","year":"2013","journal-title":"Front. Med."},{"issue":"9","key":"10.1016\/j.bone.2016.06.017_bb0065","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1210\/jc.2012-1546","article-title":"Circulating osteogenic precursor cells in type 2 diabetes mellitus","volume":"97","author":"Manavalan","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2016.06.017_bb0070","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/jbmr.1763","article-title":"Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures","volume":"28","author":"Patsch","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2016.06.017_bb0075","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1210\/jc.2012-3118","article-title":"TBS (trabecular bone score) and diabetes-related fracture risk","volume":"98","author":"Leslie","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2016.06.017_bb0080","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1007\/s00198-014-2704-7","article-title":"Bone quality assessment in type 2 diabetes mellitus","volume":"25","author":"Dhaliwal","year":"2014","journal-title":"Osteoporos. Int."},{"issue":"4","key":"10.1016\/j.bone.2016.06.017_bb0085","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/jbmr.2106","article-title":"In vivo assessment of bone quality in postmenopausal women with type 2 diabetes","volume":"29","author":"Farr","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2016.06.017_bb0090","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s11914-014-0202-7","article-title":"Diabetes, collagen, and bone quality","volume":"12","author":"Saito","year":"2014","journal-title":"Curr. Osteoporos. Rep."},{"issue":"1","key":"10.1016\/j.bone.2016.06.017_bb0095","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1210\/jc.2011-1883","article-title":"Diabetes and femoral neck strength: findings from the hip strength across the menopausal transition study","volume":"97","author":"Ishii","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.bone.2016.06.017_bb0100","doi-asserted-by":"publisher","first-page":"4804","DOI":"10.1210\/jc.2008-0639","article-title":"A bone structural basis for fracture risk in diabetes","volume":"93","author":"Melton","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bone.2016.06.017_bb0105","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1292\/jvms.11-0328","article-title":"Parathyroid hormone (1-34) improves bone mineral density and glucose metabolism in spontaneously diabetic Torii-Leprfa rats","volume":"74","author":"Kimura","year":"2012","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.bone.2016.06.017_bb0110","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1210\/en.2013-1960","article-title":"Effects of parathyroid hormone on bone mass, bone strength, and bone regeneration in male rats with type 2 diabetes mellitus","volume":"155","author":"Hamann","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2016.06.017_bb0115","author":"Forteo\u00ae PI"},{"key":"10.1016\/j.bone.2016.06.017_bb0120","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1007\/s00198-013-2284-y","article-title":"The Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) study: 2-year nonvertebral fragility fracture results","volume":"24","author":"Silverman","year":"2013","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2016.06.017_bb0125","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00198-005-1915-3","article-title":"Rationale, objectives and design of the Direct Analysis of Nonvertebral Fracture in the Community Experience (DANCE) study","volume":"17","author":"Miller","year":"2006","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2016.06.017_bb0130","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00198-011-1725-8","article-title":"Gender differences for initiating teriparatide therapy: baseline data from the Direct Assessment of Nonvertebral Fracture in the Community Experience (DANCE) study","volume":"23","author":"Wong","year":"2012","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2016.06.017_bb0135","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1002\/art.11440","volume":"49","author":"Burckhardt","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.bone.2016.06.017_bb0140","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00198-008-0766-0","article-title":"Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis","volume":"20","author":"Lindsay","year":"2009","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2016.06.017_bb0145","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2016.06.017_bb0150","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1136\/bmj.328.7447.1073","article-title":"The logrank test","volume":"328","author":"Bland","year":"2004","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.bone.2016.06.017_bb0155","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1214\/aos\/1176345693","article-title":"Piecewise exponential models for survival data with covariates","volume":"10","author":"Friedman","year":"1982","journal-title":"Ann. Stat."},{"issue":"21","key":"10.1016\/j.bone.2016.06.017_bb0160","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMsr077003","article-title":"Statistics in medicine\u2014reporting of subgroup analyses in clinical trials","volume":"357","author":"Wang","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2016.06.017_bb0165","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/009286150804200402","article-title":"Recommendations for the primary analysis of continuous endpoints in longitudinal clinical trials","volume":"42","author":"Mallinckrodt","year":"2008","journal-title":"Drug Inf. J."},{"key":"10.1016\/j.bone.2016.06.017_bb0170","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1359\/JBMR.050501","article-title":"Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment","volume":"20","author":"Prince","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2016.06.017_bb0175","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporos. Int."},{"issue":"4","key":"10.1016\/j.bone.2016.06.017_bb0180","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1359\/JBMR.041219","article-title":"Diabetes and bone loss at the hip in older black and white adults","volume":"20","author":"Schwartz","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2016.06.017_bb0185","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1359\/jbmr.080506","article-title":"Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment","volume":"23","author":"Obermayer-Pietsch","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2016.06.017_bb0190","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.berh.2014.01.002","article-title":"Osteoporosis and fragility fractures","volume":"27","author":"Gerdhem","year":"2013","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.bone.2016.06.017_bb0195","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/s00223-009-9299-6","article-title":"Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS)","volume":"85","author":"Langdahl","year":"2009","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2016.06.017_bb0200","doi-asserted-by":"publisher","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomized trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632821630179X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632821630179X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T16:16:39Z","timestamp":1568132199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S875632821630179X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":40,"alternative-id":["S875632821630179X"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2016.06.017","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Teriparatide in patients with osteoporosis and type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2016.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}